Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 USD | -0.74% | -4.10% | -12.67% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.67% | 6.85B | |
+37.15% | 705B | |
+32.42% | 583B | |
-3.11% | 364B | |
+20.18% | 332B | |
+5.69% | 291B | |
+16.81% | 238B | |
-3.60% | 210B | |
+10.46% | 209B | |
+9.39% | 169B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc - Special Call